IGFBP2 and cancer: However, epidemiological studies have shown that overexpression of IGFBP-2 is associated with aggressive phenotypes in various human cancers, including glioma, ovarian cancer, prostate cancer, pancreatic cancer, breast cancer, lung cancer, colorectal cancer, melanoma, liver cancer, gastric cancer, rhabdomyosarcoma, and leukemia (120).